These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme. Protzek AO; Rezende LF; Costa-Júnior JM; Ferreira SM; Cappelli AP; de Paula FM; de Souza JC; Kurauti MA; Carneiro EM; Rafacho A; Boschero AC J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):1-8. PubMed ID: 26386462 [TBL] [Abstract][Full Text] [Related]
4. The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice. Wang XP; Norman M; Yang J; Liu SH; Magnusson J; DeMayo FJ; Brunicardi FC J Surg Res; 2005 Nov; 129(1):64-72. PubMed ID: 16026801 [TBL] [Abstract][Full Text] [Related]
5. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance. Abdul-Hay SO; Kang D; McBride M; Li L; Zhao J; Leissring MA PLoS One; 2011; 6(6):e20818. PubMed ID: 21695259 [TBL] [Abstract][Full Text] [Related]
6. Reduced insulin clearance and lower insulin-degrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice. Rezende LF; Camargo RL; Branco RC; Cappelli AP; Boschero AC; Carneiro EM Br J Nutr; 2014 Sep; 112(6):900-7. PubMed ID: 25036874 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota impairs insulin clearance in obese mice. Foley KP; Zlitni S; Duggan BM; Barra NG; Anhê FF; Cavallari JF; Henriksbo BD; Chen CY; Huang M; Lau TC; Plante R; Schwab M; Marette A; Schertzer JD Mol Metab; 2020 Dec; 42():101067. PubMed ID: 32860984 [TBL] [Abstract][Full Text] [Related]
8. Loss of postprandial insulin clearance control by Insulin-degrading enzyme drives dysmetabolism traits. Borges DO; Patarrão RS; Ribeiro RT; de Oliveira RM; Duarte N; Belew GD; Martins M; Andrade R; Costa J; Correia I; Boavida JM; Duarte R; Gardete-Correia L; Medina JL; Raposo JF; Jones JG; Penha-Gonçalves C; Macedo MP Metabolism; 2021 May; 118():154735. PubMed ID: 33631143 [TBL] [Abstract][Full Text] [Related]
9. Acute exercise restores insulin clearance in diet-induced obese mice. Kurauti MA; Costa-Júnior JM; Ferreira SM; Dos Santos GJ; Protzek AO; Nardelli TR; de Rezende LF; Boschero AC J Endocrinol; 2016 Jun; 229(3):221-32. PubMed ID: 27000684 [TBL] [Abstract][Full Text] [Related]
11. The bile acid TUDCA reduces age-related hyperinsulinemia in mice. Zangerolamo L; Carvalho M; Barssotti L; Soares GM; Marmentini C; Boschero AC; Barbosa HCL Sci Rep; 2022 Dec; 12(1):22273. PubMed ID: 36564463 [TBL] [Abstract][Full Text] [Related]
12. Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity. Erdmann J; Mayr M; Oppel U; Sypchenko O; Wagenpfeil S; Schusdziarra V Regul Pept; 2009 Jan; 152(1-3):1-7. PubMed ID: 19026695 [TBL] [Abstract][Full Text] [Related]
13. Reduced insulin sensitivity and increased β/α cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats. Taschetto APD; Zimath PL; Silvério R; Dos Santos C; Boschero AC; Dos Santos GJ; Rafacho A Life Sci; 2021 Jul; 277():119509. PubMed ID: 33865877 [TBL] [Abstract][Full Text] [Related]
14. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Zhou YP; Berggren PO; Grill V Diabetes; 1996 May; 45(5):580-6. PubMed ID: 8621007 [TBL] [Abstract][Full Text] [Related]
15. Reduced Insulin Clearance and Insulin-Degrading Enzyme Activity Contribute to Hyperinsulinemia in African Americans. Fosam A; Sikder S; Abel BS; Tella SH; Walter MF; Mari A; Muniyappa R J Clin Endocrinol Metab; 2020 Apr; 105(4):e1835-46. PubMed ID: 32052016 [TBL] [Abstract][Full Text] [Related]